Yong Min Kim1, So Hyun Kim1, Young Suk Shim2. 1. Department of Pediatrics, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, 7, Keunjaebong-gil, Hwaseong-si, Gyeonggi-do, Seoul, 18450, Republic of Korea. 2. Department of Pediatrics, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, 7, Keunjaebong-gil, Hwaseong-si, Gyeonggi-do, Seoul, 18450, Republic of Korea. royjays0217@hallym.or.kr.
Abstract
BACKGROUND: In this study, we aimed to investigate the relationship between single-gender Korean references for non-high-density lipoprotein cholesterol (non-HDL-C) and metabolic syndrome (MetS) in childhood. METHODS: A total of 5742 Korean children aged 10-18 years who participated in a national survey were included. The subjects were classified into three groups based on single-gender non-HDL-C levels as follows: < 120 mg/dL (desirable), ≥ 120 and < 150 mg/dL (borderline high), and ≥ 150 mg/dL (high). RESULTS: Males in the borderline high non-HDL-C group had odds ratios (ORs) of 2.86 (95% confidence interval, 2.30-3.56) for elevated triglycerides (TG), 1.73 (1.08-1.79) for reduced high-density lipoprotein cholesterol (HDL-C) and 1.73 (1.08-2.78) for MetS compared with males in the desirable non-HDL-C group after adjusting for covariates. Males in the high non-HDL-C group had ORs of 1.65 (1.14-2.41) for elevated blood pressure (BP), 6.21 (4.27-9.05) for elevated TG, and 3.29 (1.49-7.26) for MetS compared with males in the desirable non-HDL-C group. Females in the borderline high non-HDL-C group had ORs of 3.03 (2.43-3.76) for elevated TG, 1.63 (1.13-2.35) for reduced HDL-C, and 4.53 (2.47-8.31) for MetS compared with females in the desirable non-HDL-C group. Females in the high non-HDL-C group had ORs of 1.43 (1.00-2.04) for elevated BP, 6.36 (4.45-9.08) for elevated TG, and 7.64 (3.65-15.96) for MetS compared with females in the desirable non-HDL-C group. CONCLUSION: Our results suggest that, in a Korean population, a non-HDL-C level of 120 mg/dL for males and 150 mg/dL for females is the threshold between borderline high and high risk for MetS.
BACKGROUND: In this study, we aimed to investigate the relationship between single-gender Korean references for non-high-density lipoprotein cholesterol (non-HDL-C) and metabolic syndrome (MetS) in childhood. METHODS: A total of 5742 Korean children aged 10-18 years who participated in a national survey were included. The subjects were classified into three groups based on single-gender non-HDL-C levels as follows: < 120 mg/dL (desirable), ≥ 120 and < 150 mg/dL (borderline high), and ≥ 150 mg/dL (high). RESULTS: Males in the borderline high non-HDL-C group had odds ratios (ORs) of 2.86 (95% confidence interval, 2.30-3.56) for elevated triglycerides (TG), 1.73 (1.08-1.79) for reduced high-density lipoprotein cholesterol (HDL-C) and 1.73 (1.08-2.78) for MetS compared with males in the desirable non-HDL-C group after adjusting for covariates. Males in the high non-HDL-C group had ORs of 1.65 (1.14-2.41) for elevated blood pressure (BP), 6.21 (4.27-9.05) for elevated TG, and 3.29 (1.49-7.26) for MetS compared with males in the desirable non-HDL-C group. Females in the borderline high non-HDL-C group had ORs of 3.03 (2.43-3.76) for elevated TG, 1.63 (1.13-2.35) for reduced HDL-C, and 4.53 (2.47-8.31) for MetS compared with females in the desirable non-HDL-C group. Females in the high non-HDL-C group had ORs of 1.43 (1.00-2.04) for elevated BP, 6.36 (4.45-9.08) for elevated TG, and 7.64 (3.65-15.96) for MetS compared with females in the desirable non-HDL-C group. CONCLUSION: Our results suggest that, in a Korean population, a non-HDL-C level of 120 mg/dL for males and 150 mg/dL for females is the threshold between borderline high and high risk for MetS.
Authors: S Matthijs Boekholdt; Benoit J Arsenault; Samia Mora; Terje R Pedersen; John C LaRosa; Paul J Nestel; R John Simes; Paul Durrington; Graham A Hitman; K M A Welch; David A DeMicco; Aeilko H Zwinderman; Michael B Clearfield; John R Downs; Andrew M Tonkin; Helen M Colhoun; Antonio M Gotto; Paul M Ridker; John J P Kastelein Journal: JAMA Date: 2012-03-28 Impact factor: 56.272
Authors: Sarah D de Ferranti; Kimberlee Gauvreau; David S Ludwig; Ellis J Neufeld; Jane W Newburger; Nader Rifai Journal: Circulation Date: 2004-10-11 Impact factor: 29.690
Authors: E Bonora; S Kiechl; J Willeit; F Oberhollenzer; G Egger; G Targher; M Alberiche; R C Bonadonna; M Muggeo Journal: Diabetes Date: 1998-10 Impact factor: 9.461
Authors: Javier A. Magaña Gomez; Daniela Moreno-Mascareño; Carla E. Angulo Rojo; Gisela Duarte de la Peña Journal: J Clin Res Pediatr Endocrinol Date: 2019-09-25